Biologic and Clinical Activity of Tivozanib (AV-951, KRN-951), a Selective Inhibitor of VEGF Receptor-1, -2, and -3 Tyrosine Kinases, in a 4-Week-On, 2-Week-Off Schedule in Patients with Advanced Solid Tumors
| Image |  |
|---|---|
| Description | scientific article published on October 5, 2011 |
| Author/s |
author: Ferry Eskens Jaap Verweij Leni van Doorn |
| Publication date | October 5, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://aacrjournals.org/clincancerres/article-pdf/17/22/7156/1999572/7156.pdf |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |